Stockreport

Norway biotech Ultimovacs plans IPO to develop cancer drug [Reuters (UK)]

Merck & Company, Inc. (new)  (MRK) 
Last merck & company, inc. (new) earnings: 4/28 06:45 am Check Earnings Report
US:NYSE Investor Relations: investors.merck.com/home/default.aspx
PDF Norway biotech Ultimovacs plans IPO to develop cancer drug | Reuters 3 Min Read OSLO (Reuters) - Norway’s Ultimovacs plans to raise around 700 million Norwegian crowns ( [Read more]